Paaladinesh "Dinesh" Thavendiranathan, MD, a scientist at Canada’s Toronto General Hospital Research Institute, recently discussed how cardiac imaging and biomarkers can significantly improve cancer patient care at the American Society of Clinical Oncology (ASCO) annual meeting.

Current Medicare performance metrics favor radiologists in large practices and those in subspecialties, which may hurt general radiologists and impact patient care.

Physicians practicing in states that implemented damage caps for malpractice claims were less likely to use angiography and more likely to use noninvasive stress testing in coronary artery disease patients.

The study in the latest edition of Research Policy, looking at the 2.3 percent excise tax imposed on medical devices in 2013, found it significantly reduced research and development investment, sales revenue, gross margins and earnings since ACA implementation in 2013.

Utilizing a 3D model in the preoperative planning of osteoplasty for a hip impingement condition can alter the location and extent of the preparation, potentially improving patient outcomes at minimal cost.

More than 20 U.S. consulate workers in Guangzhou, China, were recently evacuated after experiencing unexplained health issues caused by a suspected "auditory attack." They are currently undergoing medical screening for treatment, according to the Associated Press.

A group of researchers from the University of Missouri may have discovered two tests that could guide physicians to better treat regions of the brain responsible for communication and language.

Best known for his appearances on the TV show “Shark Tank,” Mark Cuban was part of a group of investors who helped raise millions for the non-invasive biomagnetic imaging startup.

Researchers have created a functional MRI (fMRI)-based analytical imaging method to detect and monitor blood vessel disorders and injuries in the brain without using invasive contrast agents.

PET imaging may better predict long-term benefits and guide discontinuation of therapy compared to standard contrast CT for patients with metastatic melanoma, according to findings presented at the 2018 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.